Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Feb-19 6:14 PM View:  | Burbank Jeffrey H Chief Executive Officer Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 781,646 | $30.00 | $23,449,400.00 | (100%) 781.65K to 0 | 0% |
| 25-Feb-19 5:49 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 13,077 | $30.00 | $392,310.00 | (100%) 13.08K to 0 | 0% |
| 25-Feb-19 5:35 PM View: | Donigan Heyward R Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 3,582 | $30.00 | $107,460.00 | (100%) 3.58K to 0 | 0% |
| 25-Feb-19 5:35 PM View: | Moore Craig W Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 105,439 | $30.00 | $3,163,170.00 | (100%) 105.44K to 0 | 0% |
| 25-Feb-19 5:42 PM View: | Mixer Jean K Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 16,012 | $30.00 | $480,360.00 | (100%) 16.01K to 0 | 0% |
| 25-Feb-19 5:56 PM View: | Towse Matthew W SVP and Chief Financial Office | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 28,396 | $30.00 | $851,880.00 | (100%) 28.4K to 0 | 0% |
| 25-Feb-19 5:07 PM View: | Funari Robert G Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 22,837 | $30.00 | $685,110.00 | (100%) 22.84K to 0 | 0% |
| 25-Feb-19 6:35 PM View: | Turk Joseph E Jr President | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 86,401 | $30.00 | $2,592,030.00 | (100%) 86.4K to 0 | 0% |
| 25-Feb-19 5:28 PM View: | Reid Perper Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 145,826 | $30.00 | $4,374,780.00 | (100%) 145.83K to 0 | 0% |
| 25-Feb-19 5:21 PM View: | Giannini Daniel A Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 81,389 | $30.00 | $2,441,670.00 | (100%) 81.39K to 0 | 0% |
| 25-Feb-19 3:56 PM View: | Lewis Earl R Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 100,232 | $30.00 | $3,006,960.00 | (100%) 100.23K to 0 | 0% |
| 25-Feb-19 5:35 PM View: | Moore Craig W Director | Nxstage Medical, Inc. (NXTM) | 21-Feb-19 | Disposition | 3,745 | $30.00 | $112,350.00 | (3%) 109.18K to 105.44K | 0% |
| 21-May-18 3:28 PM View: | Turk Joseph E Jr President | Nxstage Medical, Inc. (NXTM) | 21-May-18 | Option Exercise | 5,392 | $18.59 | $100,237.00 | 7% 81.01K to 86.4K | |
| 18-May-18 1:35 PM View: | Reid Perper Director | Nxstage Medical, Inc. (NXTM) | 17-May-18 | Option Exercise | 18,196 | $13.60 | $247,466.00 | 14% 127.63K to 145.83K | |
| 18-May-18 11:35 AM View: | Giannini Daniel A Director | Nxstage Medical, Inc. (NXTM) | 17-May-18 | Option Exercise | 18,196 | $13.60 | $247,466.00 | 29% 63.19K to 81.39K | |
| 18-May-18 1:42 PM View: | Moore Craig W Director | Nxstage Medical, Inc. (NXTM) | 16-May-18 | Option Exercise | 10,496 | $13.60 | $142,746.00 | 11% 94.94K to 105.44K | |
| 18-May-18 1:42 PM View: | Moore Craig W Director | Nxstage Medical, Inc. (NXTM) | 16-May-18 | Option Exercise | 7,700 | $13.60 | $104,720.00 | 7% 105.44K to 113.14K | |
| 18-May-18 1:42 PM View: | Moore Craig W Director | Nxstage Medical, Inc. (NXTM) | 16-May-18 | Payment of Exercise | 3,955 | $26.48 | $104,728.00 | (3%) 113.14K to 109.18K | (12%) |
| 16-Mar-18 4:28 PM View: | Burbank Jeffrey H Chief Executive Officer Director | Nxstage Medical, Inc. (NXTM) | 14-Mar-18 | Option Exercise | 36,273 | $18.59 | $674,315.00 | 5% 773.41K to 809.68K | |
| 16-Mar-18 4:28 PM View: | Burbank Jeffrey H Chief Executive Officer Director | Nxstage Medical, Inc. (NXTM) | 14-Mar-18 | Payment of Exercise | 28,039 | $24.05 | $674,338.00 | (3%) 809.68K to 781.65K | (23%) |
| 12-Mar-18 4:28 PM View: | Turk Joseph E Jr President | Nxstage Medical, Inc. (NXTM) | 09-Mar-18 | Payment of Exercise | 3,536 | $24.37 | $86,172.30 | (4%) 84.55K to 81.01K | (22%) |
| 12-Mar-18 4:28 PM View: | Turk Joseph E Jr President | Nxstage Medical, Inc. (NXTM) | 09-Mar-18 | Option Exercise | 11,642 | -- | -- | 16% 72.9K to 84.55K | |
| 12-Mar-18 4:21 PM View: | Burbank Jeffrey H Chief Executive Officer Director | Nxstage Medical, Inc. (NXTM) | 09-Mar-18 | Option Exercise | 17,464 | -- | -- | 2% 761.12K to 778.58K | |
| 12-Mar-18 4:21 PM View: | Burbank Jeffrey H Chief Executive Officer Director | Nxstage Medical, Inc. (NXTM) | 09-Mar-18 | Payment of Exercise | 5,167 | $24.37 | $125,920.00 | (< 1%) 778.58K to 773.41K | (22%) |
| 12-Mar-18 4:28 PM View: | Towse Matthew W SVP and Chief Financial Office | Nxstage Medical, Inc. (NXTM) | 09-Mar-18 | Option Exercise | 5,821 | -- | -- | 24% 24.42K to 30.24K | |
| 12-Mar-18 4:28 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 09-Mar-18 | Option Exercise | 4,657 | -- | -- | 48% 9.77K to 14.43K | |
| 12-Mar-18 4:28 PM View: | Towse Matthew W SVP and Chief Financial Office | Nxstage Medical, Inc. (NXTM) | 09-Mar-18 | Payment of Exercise | 1,846 | $24.37 | $44,987.00 | (6%) 30.24K to 28.4K | (22%) |
| 12-Mar-18 4:28 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 09-Mar-18 | Payment of Exercise | 1,350 | $24.37 | $32,899.50 | (9%) 14.43K to 13.08K | (22%) |
| 22-Feb-18 4:07 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Feb-18 | Market Sale (Planned) | 500 | $24.48 | $12,240.00 | (5%) 10.27K to 9.77K | (21%) |
| 22-Feb-18 4:07 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Feb-18 | Option Exercise | 3,000 | $11.03 | $33,090.00 | 29% 10.27K to 13.27K | |
| 22-Feb-18 4:07 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Feb-18 | Market Option Sale (Planned) | 3,000 | $24.48 | $73,440.00 | (23%) 13.27K to 10.27K | (21%) |
| 19-Jan-18 4:07 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 16-Jan-18 | Option Exercise | 3,000 | $11.03 | $33,090.00 | 28% 10.77K to 13.77K | |
| 19-Jan-18 4:07 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 16-Jan-18 | Market Option Sale (Planned) | 3,000 | $24.88 | $74,640.00 | (22%) 13.77K to 10.77K | (19%) |
| 19-Jan-18 4:07 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 16-Jan-18 | Market Sale (Planned) | 500 | $24.88 | $12,440.00 | (5%) 10.77K to 10.27K | (19%) |
| 21-Dec-17 4:14 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Dec-17 | Market Option Sale (Planned) | 3,000 | $25.35 | $76,050.00 | (21%) 14.27K to 11.27K | (17%) |
| 21-Dec-17 4:14 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Dec-17 | Option Exercise | 3,000 | $11.03 | $33,090.00 | 27% 11.27K to 14.27K | |
| 21-Dec-17 4:14 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Dec-17 | Market Sale (Planned) | 500 | $25.35 | $12,675.00 | (4%) 11.27K to 10.77K | (17%) |
| 14-Dec-17 4:14 PM View: | Funari Robert G Director | Nxstage Medical, Inc. (NXTM) | 12-Dec-17 | Option Exercise | 25,369 | $12.94 | $328,305.00 | 250% 10.15K to 35.52K | |
| 14-Dec-17 4:14 PM View: | Funari Robert G Director | Nxstage Medical, Inc. (NXTM) | 12-Dec-17 | Payment of Exercise | 12,682 | $25.89 | $328,337.00 | (36%) 35.52K to 22.84K | (15%) |
| 29-Nov-17 5:28 PM View: | Lewis Earl R Director | Nxstage Medical, Inc. (NXTM) | 28-Nov-17 | Gift | 8,554 | -- | -- | (8%) 108.79K to 100.23K | |
| 15-Nov-17 4:14 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 15-Nov-17 | Market Sale (Planned) | 500 | $25.73 | $12,865.00 | (4%) 11.77K to 11.27K | (15%) |
| 15-Nov-17 4:14 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 15-Nov-17 | Option Exercise | 3,000 | $11.03 | $33,090.00 | 25% 11.77K to 14.77K | |
| 15-Nov-17 4:14 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 15-Nov-17 | Market Option Sale (Planned) | 3,000 | $25.73 | $77,190.00 | (20%) 14.77K to 11.77K | (15%) |
| 27-Oct-17 4:07 PM View: | Burbank Jeffrey H Chief Executive Officer Director | Nxstage Medical, Inc. (NXTM) | 26-Oct-17 | Gift | 177,971 | -- | -- | (19%) 939.09K to 761.12K | |
| 23-Oct-17 4:28 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Oct-17 | Option Exercise | 3,000 | $11.03 | $33,090.00 | 24% 12.27K to 15.27K | |
| 23-Oct-17 4:28 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Oct-17 | Market Option Sale (Planned) | 3,000 | $27.50 | $82,500.00 | (20%) 15.27K to 12.27K | (8%) |
| 23-Oct-17 4:28 PM View: | Towse Matthew W SVP and Chief Financial Office | Nxstage Medical, Inc. (NXTM) | 20-Oct-17 | Option Exercise | 4,030 | $14.05 | $56,621.50 | 17% 24.42K to 28.45K | |
| 23-Oct-17 4:28 PM View: | Towse Matthew W SVP and Chief Financial Office | Nxstage Medical, Inc. (NXTM) | 20-Oct-17 | Market Option Sale (Planned) | 4,030 | $27.50 | $110,825.00 | (14%) 28.45K to 24.42K | (8%) |
| 23-Oct-17 4:28 PM View: | Swan Winifred L SVP and General Counsel | Nxstage Medical, Inc. (NXTM) | 20-Oct-17 | Market Sale (Planned) | 500 | $27.50 | $13,750.00 | (4%) 12.27K to 11.77K | (8%) |
| 04-Oct-17 5:07 PM View: | Turk Joseph E Jr President | Nxstage Medical, Inc. (NXTM) | 04-Oct-17 | Market Sale (Planned) | 1,000 | $27.56 | $27,560.00 | (1%) 73.9K to 72.9K | (8%) |
